PAHC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PAHC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Phibro Animal Health's dividend payout ratio for the months ended in Dec. 2023 was 0.36.
The historical rank and industry rank for Phibro Animal Health's Dividend Payout Ratio or its related term are showing as below:
During the past 13 years, the highest Dividend Payout Ratio of Phibro Animal Health was 0.57. The lowest was 0.20. And the median was 0.34.
As of today (2024-04-25), the Dividend Yield % of Phibro Animal Health is 3.80%.
During the past 13 years, the highest Trailing Annual Dividend Yield of Phibro Animal Health was 4.97%. The lowest was 0.31%. And the median was 1.78%.
Phibro Animal Health's Dividends per Share for the months ended in Dec. 2023 was $0.12.
During the past 5 years, the average Dividends Per Share Growth Rate was 3.00% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Phibro Animal Health was 6.30% per year. The lowest was 1.40% per year. And the median was 5.55% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
The historical data trend for Phibro Animal Health's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phibro Animal Health Annual Data | |||||||||||||||||||||
Trend | Jun14 | Jun15 | Jun16 | Jun17 | Jun18 | Jun19 | Jun20 | Jun21 | Jun22 | Jun23 | |||||||||||
Dividend Payout Ratio | Get a 7-Day Free Trial | 0.34 | 0.57 | 0.38 | 0.43 | 0.57 |
Phibro Animal Health Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Dividend Payout Ratio | Get a 7-Day Free Trial | 0.35 | 0.49 | 0.48 | 0.86 | 0.36 |
For the Drug Manufacturers - Specialty & Generic subindustry, Phibro Animal Health's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Phibro Animal Health's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Phibro Animal Health's Dividend Payout Ratio falls into.
Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.
Phibro Animal Health's Dividend Payout Ratio for the fiscal year that ended in Jun. 2023 is calculated as
Dividend Payout Ratio | = | Dividends per Share (A: Jun. 2023 ) | / | EPS without NRI (A: Jun. 2023 ) |
= | 0.48 | / | 0.847 | |
= | 0.57 |
Phibro Animal Health's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as
Dividend Payout Ratio | = | Dividends per Share (Q: Dec. 2023 ) | / | EPS without NRI (Q: Dec. 2023 ) |
= | 0.12 | / | 0.33 | |
= | 0.36 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phibro Animal Health (NAS:PAHC) Dividend Payout Ratio Explanation
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Thank you for viewing the detailed overview of Phibro Animal Health's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Judith Weinstein | officer: See Remarks | C/O PHIBRO ANIMAL HEALTH CORP, 300 FRANK W. BURR BOULEVARD, STE 21, TEANECK NJ 07666 |
Alejandro Bernal | director | C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054 |
E Thomas Corcoran | director | |
Larry Lee Miller | officer: Chief Operating Officer | 8 HAZELWOOD COURT, WARREN NJ 07059 |
Damian Finio | officer: Chief Financial Officer | C/O IGI LABORATORIES, INC., 105 LINCOLN AVENUE, BUENA NJ 08310 |
Robin Aukerman | officer: President,North America Region | C/O PHIBRO, GLENPOINTE CENTRE EAST, 3RD FL, 300 FRANK W. BURR BLVD, STE 21, TEANECK NJ 07666 |
Daniel M Bendheim | director, officer: Exec. VP, Corporate Strategy | 300 FRANK W. BURR BOULEVARD, SUITE 21, TEANECK NJ 07666 |
Dean J Warras | officer: Pres Animal Health & Nutr N.A. | 5113 SPYGLASS HILL, QUINCY IL 62305 |
Jack Bendheim | director, 10 percent owner, officer: President and CEO | C/O EMPIRE RESOURCES, INC., 1 PARKER PLAZA, SUIET 10, FORT LEE NJ 07024 |
Bfi Co., Llc | 10 percent owner | 300 FRANK W. BURR BLVD., STE 21, TEANECK NJ 07666 |
Jonathan Bendheim | director | GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ 07666 |
Anthony Andolino | officer: SEE REMARKS | GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., STE 21, TEANECK NJ 07666 |
Richard G Johnson | officer: Chief Financial Officer | 7 WEST 96TH STREET, APT. 11C, NEW YORK NY 10025 |
Gerald K Carlson | director | 2496 OLD BEACH ROAD, WAYZATA MN 55391 |
Thomas G Dagger | officer: SVP, Gen Counsel and Corp Sec | 41 WILCOX DRIVE, MOUNTAIN LAKES NJ 07046 |
From GuruFocus
By Business Wire • 07-25-2023
By Business Wire • 10-17-2023
By Business Wire Business Wire • 11-07-2022
By GuruFocus Research • 11-08-2023
By Business Wire • 11-07-2023
By Business Wire • 09-05-2023
By GuruFocus Research • 12-14-2023
By Business Wire Business Wire • 02-06-2023
By Business Wire Business Wire • 02-07-2022
By Business Wire Business Wire • 05-01-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.